Overview

Phase 2 Study of KH001 in Long-term Relief from Dentin Hypersensitivity

Status:
RECRUITING
Trial end date:
2025-06-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of KH001 in subjects with dentin hypersensitivity.
Phase:
PHASE2
Details
Lead Sponsor:
HysensBio Co., Ltd
Collaborator:
The Forsyth Institute